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ABSTRACT: Combining proteins or their defined domains offers new
enhanced functions. Conventionally, two proteins are either fused into a
single polypeptide chain by recombinant means or chemically cross-linked.
However, these strategies can have drawbacks such as poor expression
(recombinant fusions) or aggregation and inactivation (chemical cross-
linking), especially in the case of large multifunctional proteins. We
developed a new linking method which allows site-oriented, noncovalent,
yet irreversible stapling of modified proteins at neutral pH and ambient temperature. This method is based on two distinct
polypeptide linkers which self-assemble in the presence of a specific peptide staple allowing on-demand and irreversible
combination of protein domains. Here we show that linkers can either be expressed or be chemically conjugated to proteins of
interest, depending on the source of the proteins. We also show that the peptide staple can be shortened to 24 amino acids still
permitting an irreversible combination of functional proteins. The versatility of this modular technique is demonstrated by
stapling a variety of proteins either in solution or to surfaces.
■ INTRODUCTION
Combining proteins with different functions into a single entity
can offer new opportunities to the field of protein engineering.
Protein chimeras, made from protein building blocks that
nature already optimized for a specific function by natural
selection, could be especially attractive for multienzyme
mediated catalysis,
1 nanobiotechnology,
2 and improved medic-
inal proteins.
3,4 Proteins carrying artificially combined domains
are already widely used both in research and in medicine:
recombinant proteins are often fused to affinity tags to facilitate
their purification, fluorescent fusion proteins are used to track
their localization in cells and throughout the body, biotin−
protein conjugates are used for immobilization purposes,
antibody conjugates are widely used for detection of antigens
or for therapeutic use, and medicinal toxins can be targeted to
new localities using various targeting domains.
3,4
Despite the ever-growing interest in novel multimodular
proteins, there are factors that limit development and
production of such chimeras. A general versatile platform to
develop multimodular functional proteins is still missing and
successful production of protein chimeras still relies on an
empirical approach. Recombinant DNA technology allows
fusion of two or more modules in a single polypeptide chain;
however, this strategy may not be convenient: for example,
when production of the engineered chimera (i) leads to low
expression levels or yields insoluble protein, (ii) results in
orientation of fused parts not optimal for biological function,
(iii) raises safety issues like in the case of modified botulinum
neurotoxin,
5 or (iv) results in cytotoxicity.
6 Chemical cross-
linking, on the other hand, utilizes physically separate proteins
and relies on the reactivity of either natural (cysteine or lysine)
or non-natural amino acids.
7 Site-specific chemical conjugation
is, in practice, possible only in a limited number of cases, and
chemical-cross-linking often leads to partially inactive chimeras
or aggregated conjugates. Recently, several techniques utilized
self-assembling linkers which can be fused to proteins prior to
their assembly. ‘Protein trans-splicing’ technique utilized a split
inteinmixing of two tagged proteins allowed binding,
incision, and trans-thioesterification resulting in a covalent
bondage of the two proteins.
8 In contrast, the ‘expressed
protein ligation’ method
8 exploited the self-splicing capability of
an intein, recombinantly fused to the C-terminal of a precursor
protein, to trigger formation of α-thioester followed by trans-
thioesterification to another protein carrying N-terminal
cysteine. Both intein-based approaches require a number of
critical steps and conditions to successfully orient and bind two
precursor proteins and the conditions often cannot be
practically fulfilled. Heterodimeric leucine zippers fused to
proteins were proposed for protein linkage
9,10 but the affinity of
natural leucine zippers is not strong enough to compete with
recombinant fusion or chemical cross-linking. Another recently
introduced platform, so-called dock-and-lock platform, relies on
association of a sequence from Protein Kinase A (PKA) with A-
Kinase Anchoring Protein (AKAP).
11 Recombinant fusion of
two separate proteins of interest to the PKA and AKAP-derived
peptides allows site-oriented protein assembly. However, the
flexibility of this system is limited due to the obligatory
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introducing cysteines to stabilize the final assembled product.
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We recently described a new approach to assemble proteins
in solution using a 52 aa synthetic peptide.
5 This approach
relies on two polypeptide linkers which can be fused to proteins
of interest and then ‘stapled’ together (Figure 1) resulting in an
oriented, noncovalent, and yet irreversible complex. The linkers
and the staple are derived from the uniquely stable SNARE
coiled-coil complex.
12 Since each module can be developed and
processed separately, we performed an optimization of this
new, promising technique. Here we report that the staple can
be shortened to 24 aa still allowing firm linking of proteins. In
addition, we extend the technique to proteins which cannot be
routinely obtained by bacterial expression.
■ EXPERIMENTAL PROCEDURES
Linkers/Staple Design and Synthesis. All recombinant
proteins were expressed in BL21 strain of E. coli as glutathione-
S-transferase (GST) C-terminal fusions cleavable by thrombin.
The plasmid for expression was the pGEX-KG vector and the
design, expression, and purification of all of them, except for the
linker A-mCherry construct (see below), has been already
reported.
13,14 Briefly, the linker A corresponds to the rat
SNAP25 full-length sequence (GenBank: AAH87699.1), with
all four cysteine residues mutated to alanine; the linker B
corresponds to the rat synaptobrevin2 (NCBI Reference
Sequence: NP_036795.1), amino acids 25 to 84. GST fusion
constructs were purified by glutathione affinity chromatography
and either cleaved using thrombin or eluted with excess of
glutathione. The linker A-mCherry plasmid has been made by
introducing the mCherry sequence from pmCherry-C1 vector
(Clontech) into the EcoRI restriction site of pGEX-KG,
following SNAP25 sequence (22−206 aa; four cysteines
mutated to alanines). The botulinum neurotoxin serotype A
(BoNT/A) light chain-translocation domain (LcTd) fusion to
linker A and the linker B fusion to BoNT/A receptor binding
domain (Rbd) have been previously described in detail.
13 The
horseradish peroxidase (HRP)-linker B construct was made by
cross-linking maleimide activated HRP (ThermoScientific) to a
modified linker B peptide. The N-terminal acetylated and C-
terminal amidated modified linker B peptide, with the sequence
CGSGS RLQQT QAQVD EVVDI MRVNV DKVLE RDQKL
SELDD RADAL QAGAS, was synthesized by Peptide
Synthetics, UK, and stored in DMSO. See Supporting
Information Table 1 for the list of all the recombinant proteins
and the cross-linked conjugate used in this study.
Stapling peptides are based on rat syntaxin 1 (GenBank:
EDM13396.1) and were synthesized by Peptide Synthetics,
UK, and stored in DMSO. The native lysine was substituted
with arginine to remove primary amines; individual sequences
are shown in Figure 1B. All peptides have been modified with
an acetyl group and FITC at the N-terminus and two additional
lysine residues at the C-terminus were separated from the
syntaxin motif by a flexible aminohexanoic acid linker. This
design allows site-oriented attachment of the staples to bromo-
cyanide (BrCN)-activated Sepharose 4B resin (Amersham
Biosciences) via reactive lysines.
15 Both linkers and staples
migrate as single bands on SDS-PAGE gels (NuPAGE 10% Bis-
Tris Gel, Invitrogen) (Supporting Information Figure 1A).
Among linkers A and B, only the linker A migrates sharply on
native gels (12% Tris-HCL, Bio-Rad) (Supporting Information
Figure 1B).
Proteins Stapling and Pull-Down Assays. The stapling
reactions (Figures 2C, 4, and 5A) were performed in 20 mM
Hepes, 100 mM NaCl, 0.8% n-octylglucoside (OG), pH 7.4
(buffer A). Linkers and protein modules fused to the linkers,
were at 5 μM, and were incubated 1 h at 24 °C with a 1.5-fold
excess of relevant staple. Electrophoresis in both the native gel
in Figure 2C and the SDS-PAGE gel in Figure 5A was
performed at 4 °C to avoid overheating of the protein assembly
during the gel run. 300 μL samples of the 5 μM stapled proteins
used in Figure 4 have been analyzed by size-exclusion
chromatography to attest purity and integrity of the complexes
using an AKTA purifier 10 system (GE Healthcare). The
readouts at 280 and 490 nm have been acquired and 0.5 mL
fractions have been collected and analyzed by Coomassie
stained SDS-PAGE gels (Supporting Information Figure 2).
Pull-downs have been performed using BrCN-activated
Sepharose beads after cross-linking of the staples as previously
reported
15 (Figure 2A) or glutathione Sepharose beads after 1
h preincubation with 5 μM GST-linker fusion proteins (Figure
3). Incubations were performed in buffer A for 1 h at 24 °C
with shaking, followed by extensive washes in buffer A to
remove the unbound reagents. Fluorescence and absorbance
readings in Figure 3 were performed using Saphire 2 plate
reader (Tecan, Switzerland). Densitometry analysis of the
Coomassie stained gels (Figure 2B) has been done using the
software Quantity One v 4.5.1 (Bio-Rad). Stapled conjugates
used in this work are listed in Supporting Information Table 1.
Biacore Assay. Analysis of binding and stapling was
conducted using a Biacore 2000 system (Figures 2D, 5B, and
SI Figure 4). CM5 chip (Biacore) was used to covalently
Figure 1. Schematic of protein stapling and design of staples. (A) Two
protein modules are fused to separate linkers (yellow). In the presence
of a peptide staple (blue), they assemble into an irreversible complex.
(B) Tested staples range from 15 to 45 aa, encompassing 5 to 13
layers, characteristic of the coiled-coil SNARE complex structure.
12
Both the hydrophobic layers (boxed in gray) and so-called ‘ionic’ layer
(glutamine in red) take part in the SNARE assembly.
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combined in equimolar ratio to the staple was recorded. All
proteins/peptides were at 5 μM in buffer A and were applied to
the chip at a rate of 5 μL/min for 20 min. For stability
measurements (Figure 5B), the assembled complex was
exposed to 1% SDS for 1 min.
Hippocampal Neurons Culture and Western Immuno-
blotting. Primary cultures of hippocampal neurons were
prepared as previously described
5 and used after 7−10 days in
culture. For imaging of the uptake of the reassembled toxins
(Figure 4B), neurons were exposed to 10 nM of the indicated
compound for 2 h, DAPI-stained, fixed with 4% PFA and the
fluorescence was observed on a Radiance Confocal system
(Zeiss/Bio-Rad) linked to a Nikon Eclipse fluorescence
microscope equipped with an oil immersion objective (100×,
1.4 N.A.). The fluorescent staples alone have been used as a
negative control (SI Figure 3). For the functionality assay
(Figure 4C), neurons were incubated for 20 h with 10 nM of
the indicated compound, lysed in 60 mM Tris (pH 6.8), 2 mM
MgCl2, 2% SDS, and benzonase (250 U/mL, Novagen).
SNAP25 cleavage was then analyzed by immunobloting using
an anti-SNAP25 antibody (clone SMI81, Covance) which
recognizes both the cleaved and uncleaved proteins.
■ RESULTS
Optimization of the Staple. Syntaxin-derived SNARE
motif used previously for stapling
5 is 52 aa in length, presenting
a challenge for routine, mass-scale linking of proteins in
solution or to surfaces. To determine the minimal length of
staple (Figure 1B), we investigated the ability of chemically
synthesized peptides, covalently attached to Sepharose beads,
to pull-down linkers A and B (Figure 2A). The staples were
immobilized on BrCN Sepharose beads via two lysines and
then incubated with an excess of both linkers. As expected,
binding of both linkers to the immobilized staples occurred in
parallel and in equimolar ratio (Figure 2A). The Coomassie-
stained SDS-PAGE gel and its densitometry quantitation
(Figure 2B) show that efficient binding of linkers occurs only
when the length of staples exceeds 20 aa with the 24 aa staple
already reaching maximum. Interestingly, extending the staple
to 27 aa compromises binding of the two linkers before the
interaction recovers at the 45 aa length. Next, we exploited the
ability of linker A and stapled assemblies to migrate in native
gel electrophoresis as separate distinct bands (Figure 2C). We
incubated the staples in the presence of the two linkers in
solution for 60 min and then analyzed protein migration by
Coomassie-staining of the nondenaturing gel. Figure 2C shows
that staples as short as 20 aa can be effective in triggering
linkers association. Indeed, linker A shifts into a faster migrating
entity, most likely due to the addition of negative charges from
linker B and the staples, and/or the tight structure of the
resulting SNARE bundle.
12
To further test the efficiency of the stapling reaction we
employed the surface plasmon resonance (SPR) approach.
Linker A was immobilized on the surface of the Biacore chip
and an equimolar mixture of linker B and staple was injected
into the microfluidic chamber. Figure 2D shows the traces
acquired for each staple during the 20 min incubation. The end-
point values show that larger staples yielded faster assembly;
however, the 24 aa peptide clearly showed an increased binding
compared to its neighbors. This confirms that the 24 aa peptide
is uniquely effective in stapling reaction. Since dissociation of
the linker A/linker B/staple complex was not observed with any
of the staples used (see SI Figure 4), a dissociation constant KD
cannot be calculated. How different staples yield different
Figure 2. 24 aa and 45 aa staples exhibit the best linker binding properties. (A) Coomassie-stained SDS-PAGE gel showing the amounts of linkers A
and B bound to staples immobilized on beads. The length of peptide staples is indicated above the gel. (B) Bar chart showing integrated density (id)
values of Coomassie-stained protein bands in the SDS-PAGE gel from panel A. Note that the higher values for linker A compared to linker B are
because larger proteins bind more Coomassie stain. (C) Coomassie-stained native gel showing a shift of linker A migration after 30 min incubation in
the presence of linker B and indicated staples. (D) Biacore traces showing the stapling reaction on the chip surface carrying immobilized linker A.
The traces were obtained following the injection of the linker B mixed at equimolar ratios with different staples. Values are in resonance units (ru)
after subtraction of signals due to the loading buffer.
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currently unclear.
Stapling of Functional Proteins. Next we investigated the
efficiency of stapling proteins with diverse functions. We fused
one of the linkers to GST, functionality of which can be tested
by binding to glutathione−Sepharose beads, whereas the other
linker was fused to mCherry fluorescent protein. mCherry
provides easy readout in pull-down experiments. Figure 3B
shows that the amount of stapled mCherry has a similar trend
to that in Figure 2, confirming that the 24 and 45 aa staples
exhibit the strongest binding.
It was also important to assess the suitability of our stapling
system to protein which cannot be routinely expressed, e.g.,
HRP. We designed a modified version of linker B specifically
for the chemical cross-linking by adding a cysteine residue
which can be reacted via maleimide reaction with proteins of
interest. The modified linker B was conjugated to maleimide-
activated HRP enzyme which can be easily detected via
luminescent or colorimetric reactions. We then tested the
ability of staples to attach the HRP enzyme to GST-linker A-
containing beads in a 96-well plate. Following extensive
washing of individual wells, the amount of HRP bound to
Sepharose beads was estimated by the luminol reaction which
emits light. Exposure of an X-ray film to the 96-well plate
revealed that the HRP can be efficiently stapled to the GST-
linker A beads and that the minimal staple must be at least 24
aa long (Figure 3D). A quantitative measurement of the bound
HRP was obtained by the HRP-catalyzed colorimetric reaction
in presence of the 3,3′,5,5′-tetramethylbenzidine (TMB),
confirming the optimal length for the staple being 24 aa
(Figure 3E).
To better understand the reason for the unique efficiency of
the 24 aa staple, we analyzed the hydropathicity as a function of
peptide length (analysis performed using ProtParam tool
available at http://expasy.org/tools/protparam.html). The
Figure 3. Peptide-dependent stapling of the mCherry fluorescent
protein or horseradish peroxidase (HRP) to glutathione-S-transferase
(GST). (A) Schematic showing GST-linker (gray) immobilized on
glutathione beads which were used to pull-down mCherry (red). (B)
Histogram showing relative fluorescence units (rfu) bound to GST-
linker beads in presence of different staples. Error bars represent
standard deviation (n = 3). (C) Schematic showing GST-linker (gray)
immobilized on glutathione beads which were used to pull-down HRP.
(D) X-ray film showing relative amount of HRP bound to beads in a
96-well plate in the presence of the different staples, revealed using a
luminol reaction. (E) Histogram showing relative amount of HRP
bound to GST-linker beads in the presence of the indicated staples as
revealed by a TMB-based colorimetric reaction. (F) Plot showing
grand average of hydropathicity (GRAVY) index of the stapling
peptides as a function of their sequence and length.
Figure 4. 24 aa peptide is sufficient for stapling functional parts of
botulinum neurotoxin. (A) Schematic showing design of the
botulinum construct: the Rbd part (light blue) is stapled to the
enzymatic part (yellow), that consists of the light chain (Lc) and
translocation domain (Td). LcTd-linker A is produced as a single
protein. (B) Confocal fluorescence images showing the uptake by
hippocampal neurons of the reassembled toxins stapled with the
indicated length peptides labeled with FITC (green). Blue represents
the DAPI-stained nucleus. (C) Western immunoblot showing the
intact (upper bands) and cleaved (lower bands) endogenous SNAP25
upon incubation of hippocampal neurons with reassembled botulinum
toxin stapled with the indicated length peptides.
Figure 5. Resistance of stapled molecules to SDS. (A) A Coomassie
stained SDS-PAGE gel showing the migration of BoNT/A LcTd-Rbd
complexes stapled with the indicated length peptide. The individual
components migrate as a 120 kDa (LcTd-linker A), a 55 kDa (linker
B- Rbd) and less than 10 kDa bands (staples). Only when the staple is
45 aa long the assembly of the two modules is clearly visible in the gel
as an increase in the molecular weight. (B) Stability of stapling by the
indicated peptides under denaturing conditions. Bars indicate the
amount in resonance units (ru) of linker B remaining on linker A-
functionalized Biacore chip after incubation with 1% SDS. Error bars
represent standard deviation (n = 4).
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hydrophobic of all the stapling peptides, which may explain its
enhanced ability to drive SNARE assembly which depends on
N-to-C zippering of hydrophobic layers.
12 Extending the
syntaxin peptides beyond 24 aa incorporates the ionic layer
(see Figure 1B), bringing to the consequent drop in
hydropathicity, likely explaining why 27 aa and 34 aa have a
reduced ability to staple proteins. The hydropathicity increases
again at 45 aa, with the incorporation of more hydrophobic
layers, and the stapling efficacy increases accordingly.
Functional Testing of the 24 aa Staple. Next we tested
whether the shortened peptides can allow a stable assembly as
judged by a biologically relevant assay. We chose to staple two
functional parts of botulinum neurotoxin type A (BoNT/A),
widely known as BOTOX,
16,17 which needs to penetrate
neuronal interior to proteolyze its molecular target, the
SNAP25 protein. The two BoNT/A modules used in this
work (see the Experimental Procedures section and Supporting
Information Table 1) are the linker B - Rbd, which accomplish
the function of binding to the specific neuronal receptors, and
LcTd - linker A, whose functions are (i) translocation of the
bound and endocytosed neurotoxin from the endocytic vesicles
to the cytoplasm (Td part) and (ii) proteolysis of the target (Lc
part) that eventually impairs the fusion of the synaptic vesicles
and therefore the neurotransmitter release. Binding to neurons,
entry into the cytosol, and cleavage of the molecular target
occur only when the two modules are physically connected, and
thus the BoNT/A offers a useful paradigm to study the
functionality of the stapling method. We stapled the two
neurotoxin parts using 24 aa and 45 aa peptides, both tagged
with FITC, and applied the stapled fluorescent products to
cultured mouse hippocampal neurons. Functionality of the
stapled toxins was assessed by penetration of the fluorescently
labeled toxin into neurons and proteolytic cleavage of
intraneuronal SNAP25. Figure 4B shows that both stapled
botulinum products efficiently entered the neuronal interior
combining binding and translocation functions of the neuro-
toxin. Both the 24 and 45 aa stapled products triggered
extensive cleavage of intraneuronal SNAP25 at 10 nM
concentration, with no proteolytic cleavage detected in the
absence of staples (Figure 4C). Clearly, the translocation
module, LcTd, must be stapled to the binding part, Rbd, to be
taken up by the endocytotic machinery. This proves that a
staple as short as 24 aa is able to efficiently link the functional
modules together allowing the neurotoxin to accomplish its
sophisticated functions: binding to neuronal membranes, entry
of the botulinum enzyme into cytosol, and a highly specific
proteolysis of its intraneuronal target.
One feature of the stapling assembly is its resistance to SDS
which could be useful in verifying the success of the stapling
reaction simply by SDS-PAGE. We analyzed whether the two
stapled botulinum products, which migrate identically in a size-
exclusion chromatography (SI Figure 2), exhibit such SDS
resistance. Figure 5A shows that, only in the presence of the 45
aa staple, the botulinum product becomes SDS-resistant,
whereas SDS breaks the 24 aa stapled product into its
constituent parts. To better understand the boundary where
SDS resistance is acquired, we analyzed the resistance of linker/
staple associations to 1% SDS solution using the surface
plasmon resonance method. Figure 5B shows that only 45 aa
staple was able to confer the SDS resistance to the stapling
system, confirming possible utility of the longer linker in aiding
visualization of stapled products in SDS-PAGE gels (Figure
5A).
■ DISCUSSION
Here we described optimization of the new protein stapling
technique which allows linking of two modules using a
synthetic peptide. We demonstrated that the staple as short
as 24 amino acids in length can efficiently link proteins either in
solution or to a surface. The shortening of the staple allows an
easy and straightforward synthesis and also opens room for
incorporation of other functionalities (for example, imaging
reagents). We also demonstrated that the linkers can be
chemically cross-linked to protein building blocks. The
possibility to use the linking system for nonrecombinant
proteins opens many possibilities for conjugation of widely
used proteins such as naturally derived enzymes, lectins, growth
factors, and so forth. When recombinantly fused, the linkers
caused neither a reduction in the expression levels of proteins
tested nor solubility issues. Conceivably, the unstructured
nature of the SNARE-based linkersprior to their assem-
bly
12makes them easy to express with no deleterious effects
on the function of the building blocks. In all cases, the obtained
conjugates retained functions of individual modules.
Similarly to the intein-based protein trans-splicing technique
and the dock-and-lock platform, protein stapling requires the
expression of N-terminal and C-terminal linkers to bring
together the two parts. However, there are important
differences that can affect the choice of the ideal system for a
specific use: SNARE-based protein stapling is robust in a very
wide range of conditions while the intein mediated trans-
esterification is highly affected by the chemical contest of the
reaction or requires additional disulfide bridging in the case of
the dock-and-lock platform. A sortase-driven protein con-
jugation, on the other hand, requires millimolar calcium and
elevated pH and temperatures, limiting its utility.
18 SNARE-
based protein stapling does not result in the formation of the
peptide bond between the two parts, but allows parallel
incorporation of chemical agents, e.g., fluorophores or other
labeling compounds. Finally, while intein-based trans-splicing
may allow reconstitution of a desired split-protein with fully
preserved structure, the protein stapling evidently permits
combinations of structurally unrelated proteins and thus could
be suitable for production of multienzyme complexes, anti-
body−enzyme conjugates, heterofunctional targeting agents for
binding two receptors, and so forth. The stapling mechanism
between the two stapled domains can potentially give new
beneficial features to the assembled product as was previously
demonstrated for the stapled BoNT/A (preserved silencing of
central neurons without muscle paralytic activity).
13
In summary, we optimized the protein stapling method
making it more attractive for protein engineering: (i) a
functional peptide staple that is half the length of the previously
reported, (ii) the possibility to cross-link a synthetic SNARE
linker to a protein obtained by sources other than recombinant
(e.g., HRP), and (iii) the possibility to immobilize a SNARE
linker fusion protein to a surface through a staple (e.g., on a
Biacore chip). Finally, we highlighted the possibility to follow
supramolecular assembly by SDS-PAGE when using a 45 amino
acid staple.
It is likely that future design and synthesis of supramolecular
complexes and molecular machines made from heterologous
protein domains
1,2,19,20 will be based on a modular approach.
Clearly, production of individual building blocks carrying
Bioconjugate Chemistry Article
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chemical cross-linking. However, once the expression of a
SNARE linker-fusion protein is established, it will be
straightforward to staple it to many protein or synthetic
entities, fulfilling the step-by-step nature of the modular
approach. On the contrary, the recombinant fusion of many
different chimeras could be problematic in terms of time,
different levels of expression, or even impossibility to synthesize
the protein. Another specific advantage of the stapling method
is the possibility to easily create protein−synthetic molecule
conjugates. Pertinently, the fast SNARE-based assembly
happens when the linkers and staple are at equimolar
concentrations, while chemical cross-linking often requires a
large excess of one of the reagents, leading to losses of valuable
material and potential denaturation or aggregation. Moreover,
the quick and robust self-assembling and the potential to
visualize the assembled products in less than one hour together
present a uniquely versatile platform for combinatorial
assembly of multifunctional proteins.
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